Triggered by encouraging Phase I data in prostate cancer, a randomized, controlled Phase II study of tecemotide in combination with standard androgen deprivation therapy ADT and RTX for newly diagnosed, high risk prostate cancer patients was initiated at the US
promethazine in canada Either would be OK, as your Electrolytes aren t really bad right now